SCHEMBL4776053

SCHEMBL4776053

COc1ccc(C)cc1C1CC1C(=O)Nc1sc2c(c1C#N)CCNC2

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
POLB P06746 6/20 0.44
SMN1; SMN2 Q16637 5/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NPC1 O15118 4/20 0.43
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
TGFBR1 P36897 2/20 0.41
MAPT P10636 4/20 0.40
KDM4E B2RXH2 2/20 0.40
RAB9A P51151 3/20 0.40
HPGD P15428 2/20 0.40
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
TP53 P04637 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4771021 0.92 TGFBR1 (0.48) ALDH1A1POLBSMN1; SMN2L3MBTL1NPC1
SCHEMBL4766163 0.91 RAB9A (0.41) ALDH1A1POLBSMN1; SMN2L3MBTL1NPC1
SCHEMBL4960989 0.90 NPC1 (0.44) ALDH1A1POLBSMN1; SMN2NPC1KMT2A
SCHEMBL2894804 0.89 NPC1 (0.49) ALDH1A1POLBSMN1; SMN2L3MBTL1NPC1
SCHEMBL4961397 0.88 ALDH1A1 (0.41) ALDH1A1POLBSMN1; SMN2NPC1KMT2A
SCHEMBL4766464 0.87 POLB (0.48) ALDH1A1POLBSMN1; SMN2L3MBTL1NPC1
SCHEMBL4766038 0.85 POLB (0.48) ALDH1A1POLBSMN1; SMN2L3MBTL1NPC1
SCHEMBL4768814 0.85 TGFBR1 (0.44) ALDH1A1POLBSMN1; SMN2L3MBTL1NPC1
SCHEMBL4766403 0.85 TGFBR1 (0.43) ALDH1A1POLBSMN1; SMN2L3MBTL1NPC1
SCHEMBL4767800 0.84 POLB (0.47) ALDH1A1POLBSMN1; SMN2L3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893618-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER Nycomed GmbH (DE) 2008-03-05 EP disclosed
WO-2006125815-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER NYCOMED GMBH (DE) 2006-11-30 WO disclosed